News from advanceCOR
Company news and press reports: Here you can find out how we inform the public and what the media is writing about us.
Our press releases
2020
May 2020 – Further financing round with a consortium of investors completed. – Read text as PDF
February 2020 – Milestone in novel therapy of M. Basedow reached. – Read text as PDF
January 2020 – Phase II study with Revacept for stroke successfully completed. – Read text as PDF
2019
May 2019 – advanceCOR secures rights to anti-GPVI antibodies from Morphosys – Read text as PDF
2018
December 2018 – Patient recruitment for Phase II study with Revacept completed. – Read text as PDF
2016
May 2016 – BMBF supports advanceCOR projects in the programme “Individualised Medicine”. – Read text as PDF
2015
August 2015 – Second financing round closed. MIG AG as main investor. – Read text as PDF
2013
April 2013 – Phase II study with Revacept in acute stroke/TIA initiated. – Read text as PDF
March 2013 – First financing round closed. Main investor: MIG AG. – Read text as PDF
Media reports about us
2020
June, 16, 2020 – “advanceCOR closes another financing round of EUR 3.9 million”, in: goingpublic.de – The capital markets portal – Read text online
June, 3, 2020: “Thrombosis: Fresh money for therapy option”, in: transcript – economy technology life – Read text online
2018
2018 – “With fresh money into the heartbeat final”, in: transcript – Economy Technology Life, Issue 7-8/2018 – Read text online